Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.
Momeny M, Eyvani H, Barghi F, Ghaffari SH, Javadikooshesh S, Hassanvand Jamadi R, Esmaeili F, Alishahi Z, Zaghal A, Bashash D, Samani FS, Ghaffari P, Dehpour AR, Tavangar SM, Alimoghaddam K, Ghavamzadeh A.
Momeny M, et al.
Anticancer Drugs. 2018 Nov;29(10):1011-1020. doi: 10.1097/CAD.0000000000000681.
Anticancer Drugs. 2018.
PMID: 30096128